196 related articles for article (PubMed ID: 34730214)
41. Association of OSR-1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease.
Kocyigit I; Taheri S; Eroglu E; Zararsiz G; Sener EF; Uzun I; Imamoglu H; Mehmetbeyoglu E; Unal A; Korkmaz K; Sipahioglu MH; Oymak O; Tokgoz B
Ther Apher Dial; 2020 Feb; 24(1):64-71. PubMed ID: 31020807
[TBL] [Abstract][Full Text] [Related]
42. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
Masoumi A; Elhassan E; Schrier RW
Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
[TBL] [Abstract][Full Text] [Related]
43. Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease.
Lai S; Mittherhofer AP; Cianci R; Riviello L; Vocaturi M; Mastroluca D; Ciccariello M; Von Heland M; Ricciuti GP; Salciccia S; Mazzaferro S
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2734-2743. PubMed ID: 31002123
[TBL] [Abstract][Full Text] [Related]
44. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
Lawson CR; Doulton TW; MacGregor GA
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
[TBL] [Abstract][Full Text] [Related]
45. Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy.
Deguchi K; Sasaki I; Tsukaguchi M; Kamoda M; Touge T; Takeuchi H; Kuriyama S
J Neurol Sci; 2002 Jul; 199(1-2):31-7. PubMed ID: 12084439
[TBL] [Abstract][Full Text] [Related]
46. Prospective change in renal volume and function in children with ADPKD.
Cadnapaphornchai MA; McFann K; Strain JD; Masoumi A; Schrier RW
Clin J Am Soc Nephrol; 2009 Apr; 4(4):820-9. PubMed ID: 19346430
[TBL] [Abstract][Full Text] [Related]
47. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
[TBL] [Abstract][Full Text] [Related]
48. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
[TBL] [Abstract][Full Text] [Related]
49. Systemic Succinate, Hypoxia-Inducible Factor-1 Alpha, and IL-1β Gene Expression in Autosomal Dominant Polycystic Kidney Disease with and without Hypertension.
Kocyigit I; Taheri S; Eroglu E; Sener EF; Zararsız G; Uzun I; Tufan E; Mehmetbeyoglu E; Korkmaz Bayramov K; Sipahioglu MH; Ozkul Y; Tokgoz B; Oymak O; Axelsson J
Cardiorenal Med; 2019; 9(6):370-381. PubMed ID: 31319406
[TBL] [Abstract][Full Text] [Related]
50. Hypertension in children with autosomal dominant polycystic kidney disease (ADPKD).
Cadnapaphornchai MA
Curr Hypertens Rev; 2013 Feb; 9(1):21-6. PubMed ID: 23971640
[TBL] [Abstract][Full Text] [Related]
51. The Effect of Smoking on Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease Patients with Preserved Renal Function.
Gul CB; Yildiz A; Sag S; Oruc A; Ersoy A; Gullulu S
Ren Fail; 2021 Dec; 43(1):1124-1129. PubMed ID: 34256663
[TBL] [Abstract][Full Text] [Related]
52. Role of renin-angiotensin-aldosterone system and of sympathetic activity in arterial hypertension associated with autosomal dominant polycystic kidney disease.
Cerasola G; Li Vecchi M; Mulé G; Cottone S; Mangano MT; Andronico G; Contomo A; Parrino IA; Renda F; Pavone G; Scialabba A
Contrib Nephrol; 1997; 122():22-7. PubMed ID: 9399032
[No Abstract] [Full Text] [Related]
53. Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.
Heffernan KS; Kuvin JT; Sarnak MJ; Perrone RD; Miskulin DC; Rudym D; Chandra P; Karas RH; Menon V
Nephrol Dial Transplant; 2011 Aug; 26(8):2515-21. PubMed ID: 21292815
[TBL] [Abstract][Full Text] [Related]
54. Morphological evaluation of sympathetic renal innervation in patients with autosomal dominant polycystic kidney disease.
Rovella V; Scimeca M; Giannini E; D'Ercole A; Giacobbi E; Noce A; D'Urso G; Anselmo A; Bove P; Santeusanio G; Bonanno E; Casasco M; Mauriello S; Di Daniele N; Mauriello A; Anemona L
J Nephrol; 2020 Feb; 33(1):83-89. PubMed ID: 31025246
[TBL] [Abstract][Full Text] [Related]
55. Optimal care of autosomal dominant polycystic kidney disease patients.
Schrier RW
Nephrology (Carlton); 2006 Apr; 11(2):124-30. PubMed ID: 16669974
[TBL] [Abstract][Full Text] [Related]
56. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
Devuyst O
J Nephrol; 2003; 16(3):449-52. PubMed ID: 12832751
[TBL] [Abstract][Full Text] [Related]
57. Prolonged QT interval and reduced heart rate variability in patients with uncomplicated essential hypertension.
Maule S; Rabbia F; Perni V; Tosello F; Bisbocci D; Mulatero P; Veglio F
Hypertens Res; 2008 Nov; 31(11):2003-10. PubMed ID: 19098371
[TBL] [Abstract][Full Text] [Related]
58. Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.
Gul CB; Yildiz A; Ersoy A; Kahvecioglu S; Asiltas B; Yildirim F; Ermurat S; Sag S; Oruc A; Gullulu S; Gullulu M
Int Urol Nephrol; 2015 Jul; 47(7):1187-94. PubMed ID: 26047596
[TBL] [Abstract][Full Text] [Related]
59. Renal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1-deficient mice.
Fonseca JM; Bastos AP; Amaral AG; Sousa MF; Souza LE; Malheiros DM; Piontek K; Irigoyen MC; Watnick TJ; Onuchic LF
Kidney Int; 2014 May; 85(5):1137-50. PubMed ID: 24429399
[TBL] [Abstract][Full Text] [Related]
60. Urine concentration ability is reduced to the same degree in adult dominant polycystic kidney disease compared with other chronic kidney diseases in the same CKD-stage and lower THAN in healthy control subjects - a CASE control study.
Malmberg MH; Mose FH; Pedersen EB; Bech JN
BMC Nephrol; 2020 Aug; 21(1):379. PubMed ID: 32867720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
